James Edward Bass - Net Worth and Insider Trading
James Edward Bass Net Worth
The estimated net worth of James Edward Bass is at least $18 Million dollars as of 2025-05-06. James Edward Bass is the Director of Reata Pharmaceuticals Inc and owns about 105,084 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $18 Million. Details can be seen in James Edward Bass's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Edward Bass has not made any transactions after 2019-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Edward Bass
James Edward Bass Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Edward Bass owns 1 companies in total, including Reata Pharmaceuticals Inc (RETA) .
Click here to see the complete history of James Edward Bass’s form 4 insider trades.
Insider Ownership Summary of James Edward Bass
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2019-03-05 | director |
James Edward Bass Latest Holdings Summary
James Edward Bass currently owns a total of 1 stock. James Edward Bass owns 105,084 shares of Reata Pharmaceuticals Inc (RETA) as of March 5, 2019, with a value of $18 Million.
Latest Holdings of James Edward Bass
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2019-03-05 | 105,084 | 172.36 | 18,112,278 |
Holding Weightings of James Edward Bass
James Edward Bass Form 4 Trading Tracker
According to the SEC Form 4 filings, James Edward Bass has made a total of 0 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 5,852 shares on March 5, 2019, which brought James Edward Bass around $586,897.
Insider Trading History of James Edward Bass
- 1
James Edward Bass Trading Performance
GuruFocus tracks the stock performance after each of James Edward Bass's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Edward Bass is 23.1%. GuruFocus also compares James Edward Bass's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Edward Bass within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Edward Bass's insider trading performs compared to the benchmark.
Performance of James Edward Bass
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.93 | | | | | |
| Relative Return to S&P 500(%) | 11.54 | | | | | |
James Edward Bass Ownership Network
Ownership Network List of James Edward Bass
Ownership Network Relation of James Edward Bass
James Edward Bass Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
James Edward Bass is the director of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , SVP & Chief Accounting Officer Bhaskar Anand , and EVP & Chief R&D Officer Rajiv Patni .
Reata Pharmaceuticals Inc (RETA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc (RETA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reata Pharmaceuticals Inc (RETA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Reata Pharmaceuticals Inc (RETA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
James Edward Bass Mailing Address
Above is the net worth, insider trading, and ownership report for James Edward Bass. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James Edward Bass's mailing address is: Irving Tx 75063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
